Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT01699737. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of JTT-851 in Patients With Type 2 Diabetes Mellitus
Study identification
- NCT ID
- NCT01699737
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Akros Pharma Inc.
- Industry
- Enrollment
- 325 participants
Conditions and interventions
Conditions
Interventions
- Glimepiride Drug
- JTT-851 Drug
- Placebo for Active Drug
- Placebo for comparator Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2012
- Primary completion
- Apr 30, 2013
- Completion
- Jun 30, 2013
- Last update posted
- Jul 31, 2013
2012 – 2013
United States locations
- U.S. sites
- 79
- U.S. states
- 27
- U.S. cities
- 79
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Dothan | Alabama | — | — |
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Montgomery | Alabama | — | — |
| Not listed | Muscle Shoals | Alabama | — | — |
| Not listed | Glendale | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Artesia | California | — | — |
| Not listed | Beverly Hills | California | — | — |
| Not listed | Buena Park | California | — | — |
| Not listed | Chino | California | — | — |
| Not listed | Garden Grove | California | — | — |
| Not listed | Lincoln | California | — | — |
| Not listed | Lomita | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Newport Beach | California | — | — |
| Not listed | North Hollywood | California | — | — |
| Not listed | Paramount | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | Spring Valley | California | — | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Cooper City | Florida | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Kissimee | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Miramar | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Ormond Beach | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Port Orange | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Columbus | Georgia | — | — |
| Not listed | Marietta | Georgia | — | — |
| Not listed | Nampa | Idaho | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Evanston | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Lake Charles | Louisiana | — | — |
| Not listed | New Orleans | Louisiana | — | — |
| Not listed | Oxon Hill | Maryland | — | — |
| Not listed | Olive Branch | Mississippi | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Berlin | New Jersey | — | — |
| Not listed | Mine Hill | New Jersey | — | — |
| Not listed | Glen Falls | New York | — | — |
| Not listed | Greensboro | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Kettering | Ohio | — | — |
| Not listed | Marion | Ohio | — | — |
| Not listed | Munroe Falls | Ohio | — | — |
| Not listed | Wadsworth | Ohio | — | — |
| Not listed | Norman | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Eugene | Oregon | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Lansdale | Pennsylvania | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Carrollton | Texas | — | — |
| Not listed | Corpus Christi | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Sugarland | Texas | — | — |
| Not listed | Tomball | Texas | — | — |
| Not listed | Murray | Utah | — | — |
| Not listed | Orem | Utah | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Burke | Virginia | — | — |
| Not listed | Manassas | Virginia | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Suffolk | Virginia | — | — |
| Not listed | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01699737, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2013 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01699737 live on ClinicalTrials.gov.